🇺🇸 Methotrexate; sulfasalazine; hydroxychloroquine;leflunomide in United States

Methotrexate; sulfasalazine; hydroxychloroquine;leflunomide (Methotrexate; sulfasalazine; hydroxychloroquine;leflunomide) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Methotrexate; sulfasalazine; hydroxychloroquine;leflunomide in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Methotrexate; sulfasalazine; hydroxychloroquine;leflunomide approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Methotrexate; sulfasalazine; hydroxychloroquine;leflunomide in United States?

Wyeth is now a wholly owned subsidiary of Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.